Pericardial effusion in a patient with a history of cancer should always prompt a hypothesis of malignant involvement. We report the case of a 66-year-old white woman presenting with pericardial effusion 25 years after a mastectomy for ductal breast carcinoma. This is one of the cases with the latest recurrence ever reported.
SchneiderI.J., d'OrsiE.: Five-year survival and prognostic factors in women with breast cancer in Santa Catarina State, Brazil.Cad Saude Publica, 25: 1285–1296, 2009.
2.
BedardP.L., DiL.A., Piccart-GebhartM.J.: Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.Nat Rev Clin Oncol, 7: 22–36, 2010.
3.
BedardP.L., CardosoF.: Recent advances in adjuvant systemic therapy for early-stage breast cancer.Ann Oncol,19(Suppl 5): v122–v127, 2008.
ForbesJ.F., CuzickJ., BuzdarA., HowellA., TobiasJ.S., BaumM.: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the AT-AC trial.Lancet Oncol, 9: 45–53, 2008.
6.
WeissR.B., WoolfS.H., DemakosE., HollandJ.F., BerryD.A., FalksonG., CirrincioneC.T., RobbinsA., BothunS., HendersonI.C., NortonL.; Cancer and Leukemia Group B: Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.J Clin Oncol 2003, 21: 1825–1835, 2003.
7.
SkhvatsabajaL.V.: Secondary malignant lesions of the heart and pericardium in neoplastic disease.Oncology, 43: 103–106, 1986.
8.
ThurberD.L., EdwardsJ.E., AchorR.W.: Secondary malignant tumors of the pericardium.Circulation, 26: 228–241, 1962.
9.
WilkesJ.D., FidiasP., VaickusL., PerezR.P.: Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute.Cancer, 76: 1377–1387, 1995.
10.
MaherE.A., ShepherdF.A., ToddT.J.: Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade.J Thorac Cardiovasc Surg, 112: 637–643, 1996.
11.
LiuG., CrumpM., GossP.E., DanceyJ., ShepherdF.A.: Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade.J Clin Oncol, 14: 3141–3147, 1996.
12.
WangP.C., YangK.Y., ChaoJ.Y., LiuJ.M., PerngR.P., YenS.H.: Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer.Chest, 118: 744–749, 2009.
13.
LahamR.J., CohenD.J., KuntzR.E., BaimD.S., LorellB.H., SimonsM.: Pericardial effusion in patients with cancer: outcome with contemporary management strategies.Heart, 75: 67–71, 1996.
14.
CelermajerD.S., BoyerM.J., BaileyB.P., TattersallM.H.: Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients.Med J Aust, 154: 19–22, 1991.
